Heart Test Laboratories Inc. (HSCS): רווח נקי למניה (EPS TTM)
The clinical validation of the Heart Test Laboratories (HSCS) AI platform is creating the primary growth impulse. The TTM annual earnings per share trend on the GURU.Markets chart, where the value -3.22 reflects the current figure, links the trend to fundamentals. The brand is valued for its precision in diagnosing hidden pathologies, while revenue is based on the implementation of cloud software and intelligent ECG systems.
פילוחים אנליטיים ודוחות נתונים של חברת Heart Test Laboratories, Inc. (HSCS)
To minimize speculative risks, investors must separate market noise from actual business profitability. This metric is calculated as the ratio of net income to the total number of shares outstanding over the last 12 months. By analyzing the trailing twelve-month (TTM) earnings per share, one can assess the stability of fundamental income. For Heart Test Laboratories (HSCS), this trend confirms the effectiveness of the transition to a subscription model. The growth of this indicator signals the successful monetization of a narrow AI diagnostics niche.
